RBP4 and COVID-19: The associations between RBP4 with COVID-19 hospitalization (OR: 0.76, 95% CI: 0.58-1.00, P: 0.0505) and severity (OR: 0.86, 95% CI: 0.73–1.02, P: 0.0788) were not significant.